Overview
Claudia Nothling practices practicing medicine in Freiburg, Germany.
Her clinical expertise encompasses Endometrial Cancer, Triple-Negative Breast Cancer, and Ovarian Cancer.
She is actively involved in clinical research, co-authoring 8 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Claudia Nothling
Is Claudia Nothling a top-rated expert for Endometrial Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Claudia Nothling is classified as an Experienced expert for Endometrial Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Claudia Nothling participate in research or clinical trials?
Yes. Claudia Nothling has published 8 articles and abstracts on conditions like Endometrial Cancer. You can view a list of Claudia Nothling's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Endometrial CancerMs. Nothling isExperienced. Learn about Endometrial Cancer.
- Ovarian CancerMs. Nothling isExperienced. Learn about Ovarian Cancer.
- Triple-Negative Breast CancerMs. Nothling isExperienced. Learn about Triple-Negative Breast Cancer.